US8560084B2 - Lead body with inner and outer co-axial coils - Google Patents
Lead body with inner and outer co-axial coils Download PDFInfo
- Publication number
- US8560084B2 US8560084B2 US13/220,913 US201113220913A US8560084B2 US 8560084 B2 US8560084 B2 US 8560084B2 US 201113220913 A US201113220913 A US 201113220913A US 8560084 B2 US8560084 B2 US 8560084B2
- Authority
- US
- United States
- Prior art keywords
- electrical conductors
- inner coil
- insulator
- coil
- insulated wires
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01B—CABLES; CONDUCTORS; INSULATORS; SELECTION OF MATERIALS FOR THEIR CONDUCTIVE, INSULATING OR DIELECTRIC PROPERTIES
- H01B7/00—Insulated conductors or cables characterised by their form
- H01B7/04—Flexible cables, conductors, or cords, e.g. trailing cables
- H01B7/048—Flexible cables, conductors, or cords, e.g. trailing cables for implantation into a human or animal body, e.g. pacemaker leads
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/49117—Conductor or circuit manufacturing
- Y10T29/49169—Assembling electrical component directly to terminal or elongated conductor
Definitions
- the present disclosure relates to a lead body with inner and outer co-axial coils each having a plurality of discrete electrical paths.
- the inner and outer coils are in direct physical contact and coiled in opposite directions.
- the human body imposes stringent requirements on electrical conductors that are implanted in it. Leads inserted in a living body that form a part of a stimulation and/or measuring device are subjected to almost continuous flexure during body movement. Also, a living body constitutes a site that is chemically and biologically hostile to anything that invades it. Consequently, leads ideally have good deformability, particularly bending ability, high fatigue resistance, corrosion resistance, and a high degree of electric conductance.
- U.S. Pat. No. 4,640,983 discloses a lead body having at least one spiral which is formed from at least one conductor. Each conductor consists of wires that are stranded together to form a bundle. The wires belonging to a conductor can all consist of the same material or of different materials, one of which has a large breaking strength and the other one having high electric conductivity.
- One embodiment discloses inner and outer coils wound in the same direction and separated by an insulating sheath.
- U.S. Pat. No. 5,483,022 discloses a lead body having at least one helical coil formed from at least one electrical cable. Each cable is formed from several wires twisted in a ropelike configuration. Each wire is a composite of a core of a highly conductive material and a coveting of a strong and biocompatible material, with all adjacent wires belonging to the same cable in un-insulated contact with each other.
- One embodiment discloses inner and outer coils wound in the same direction and separated by an insulating sheath.
- U.S. Pat. No. 6,978,185 discloses a lead body having electrically active and inactive elements helically wound together. The active elements are separated from each other by the inactive elements.
- One embodiment discloses inner and outer coils wound in opposite directions and separated by an insulating sheath.
- the present disclosure relates to a lead body with inner and outer co-axial coils each having a plurality of discrete electrical paths.
- the inner and outer coils are coiled in opposite directions and in direct physical contact with each other.
- Embodiments with twelve discrete electrical paths are disclosed.
- the conductor device provides a relatively high electric conductance with great flexibility, expandability, breaking strength and, in particular, fatigue resistance.
- One embodiment is directed to a biomedical conductor assembly adapted for at least partial insertion in a living body.
- the conductor assembly includes a plurality of first and second electrical conductors each covered with an insulator.
- a plurality of the first electrical conductors are helically wound in a first direction to form an inner coil with a lumen and a plurality of the second electrical connectors helically wound in a second opposite direction forming an outer coil in direct physical contact with the inner coil.
- An insulator covers the inner and outer coils.
- the plurality of second electrical conductors each include a plurality of un-insulated wires twisted in a ropelike configuration around a central axis to form a plurality of cables. Each cable is covered with an insulator.
- the un-insulated wires are preferably movable with respect to each within the insulator.
- the inner coil preferably slides relative to the outer coil within the conductor assembly.
- the first electrical conductors each optionally include a plurality of discrete insulated wires.
- the first electrical conductors optionally include a plurality of un-insulated wires twisted in a ropelike configuration around a central axis to form a cable wherein each cable is covered with an insulator.
- the un-insulated wires in the second electrical conductors include a core of a first material surrounded by a covering of a second material.
- the second electrical conductors include a center wire and a plurality of un-insulated wires twisted in a ropelike configuration around the center wire. The center wire preferably has a greater breaking strength than the un-insulated wires.
- the conductor assembly can include any number of discrete conductors.
- the inner coil includes four discrete insulated wires and the outer coil includes four or eight discrete insulated cables.
- the conductor assembly includes a plurality of the first electrical conductors each covered with an insulator and helically wound in a first direction to form an inner coil with a lumen.
- the second electrical conductors each including a plurality of un-insulated wires twisted in a ropelike configuration around a central axis to form a plurality of cables covered with an insulator.
- the inner and outer coils are covered by an insulator.
- the present disclosure is also directed to a therapy delivery element including an elongated lead body having a proximal end and a distal end.
- the lead body includes a plurality of the first electrical conductors each covered with an insulator and helically wound in a first direction to form an inner coil with a lumen and a plurality of second electrical conductors each including a plurality of un-insulated wires twisted in a ropelike configuration around a central axis to form a plurality of cables.
- Each cable is covered with an insulator and helically wound in a second opposite direction forming an outer coil in direct physical contact with the inner coil.
- An insulator covers the inner and outer coils.
- At least one electrically conductive connector is operatively associated with the proximal end of the lead body and at least one electrode is operatively associated with the distal end of the lead body.
- Each matched set of connectors and electrodes are electrically coupled with one of the first or second electrical conductors.
- the therapy delivery element preferably includes a stylet wire having a distal end inserted into the lumen through an opening at the proximal end of the lead body and a proximal end attached to a stylet handle.
- the present disclosure is also directed to a neurostimulation system including an implantable pulse generator and a therapy delivery element in accordance with an embodiment of the present disclosure.
- a stylet wire having a distal end is inserted into the lumen through an opening at the proximal end of the lead body and a proximal end attached to a stylet handle.
- the present disclosure is also directed to a method of making a therapy delivery element adapted for at least partial insertion in a living body.
- the method includes helically winding a plurality of the first electrical conductors each covered with an insulator in a first direction to form an inner coil with a lumen.
- a plurality of second electrical conductors is helically wound in a second opposite direction forming an outer coil in direct physical contact with the inner coil.
- Each of the second electrical conductors includes a plurality of un-insulated wires twisted in a ropelike configuration around a central axis to form a plurality of cables covered with an insulator.
- An insulating covering is applied to the inner and outer coils to form a lead body.
- At least one electrically conductive connector is attached to a proximal end of the lead body and at least one electrode is attached to a distal end of the lead body.
- Each matched set of connectors and electrodes are electrically coupled with one of the first or second electrical conductors.
- the present disclosure is also directed to a method of implanting a neurostimulation system.
- the method includes grasping a stylet handle attached to a stylet wire inserted into a lumen of a therapy delivery element in accordance with an embodiment of the present disclosure.
- the electrodes at a distal end of a therapy delivery element are steered to a target location within the living body.
- the stylet is removed from the therapy delivery element.
- An implantable pulse generator is implanted within the living body.
- the electrical contacts at the proximal end of the therapy delivery element are electrically coupled with the implantable pulse generator.
- FIG. 1 is a schematic illustration of a therapy delivery system.
- FIG. 2 is a schematic illustration of an environment for a therapy delivery system in accordance with an embodiment of the present disclosure.
- FIG. 3 is an alternate illustration of the environment for an implantable pulse generator with a therapy delivery element in accordance with an embodiment of the present disclosure.
- FIG. 4A is a schematic illustration of an implantable pulse generator and a therapy delivery element in accordance with an embodiment of the present disclosure.
- FIG. 4B is a schematic illustration of a lead extension and a therapy delivery element in accordance with an embodiment of the present disclosure.
- FIG. 5A is a schematic illustration of a stylet-lead assembly in accordance with an embodiment of the present disclosure.
- FIG. 5B is an exploded view of the stylet-lead assembly of FIG. 5A .
- FIGS. 6A and 6B are sectional views of a lead body in accordance with an embodiment of the present disclosure.
- FIG. 6C is a sectional view of an electrical conductor including a plurality of un-insulated wires in accordance with an embodiment of the present disclosure.
- FIGS. 7A-7D are side sectional views of various conductor assemblies in accordance with an embodiment of the present disclosure.
- FIG. 8 is a flow chart of a method of making a stylet in accordance with an embodiment of the present disclosure.
- FIG. 9 is a flow chart of a method of implanting a neurostimulation system in accordance with an embodiment of the present disclosure.
- the description that follows relates to spinal cord stimulation (SCS) system.
- SCS spinal cord stimulation
- the present disclosure lends itself well to applications in SCS, the disclosure in its broadest aspects may not be so limited. Rather, the disclosure may be used with any type of implantable therapy delivery system with one or more therapy delivery elements.
- the present disclosure may be used as part of a pacemaker, a defibrillator, a cochlear stimulator, a retinal stimulator, a stimulator configured to produce coordinated limb movement, a cortical stimulator, a deep brain stimulator, peripheral nerve stimulator, microstimulator, or in any other neural stimulator configured to treat urinary incontinence, sleep apnea, shoulder sublaxation, headache, etc.
- one or more of the therapy delivery elements may be a fluid delivery conduit, such as a catheter, including an inner lumen that is placed to deliver a fluid, such as pharmaceutical agents, insulin, pain relieving agents, gene therapy agents, or the like from a fluid delivery device (e.g., a fluid reservoir and/or pump) to a respective target tissue site in a patient.
- a fluid delivery device e.g., a fluid reservoir and/or pump
- one or more of the therapy delivery elements may be an electrical lead including one or more sensing electrodes to sense physiological parameters (e.g., blood pressure, temperature, cardiac activity, etc.) at a target tissue site within a patient.
- therapy may include stimulation therapy, sensing or monitoring of one or more physiological parameters, fluid delivery, and the like.
- Therapy delivery element includes pacing or defibrillation leads, stimulation leads, sensing leads, fluid delivery conduit, and any combination thereof
- Target tissue site refers generally to the target site for implantation of a therapy delivery element, regardless of the type of therapy.
- FIG. 1 illustrates a generalized therapy delivery system 10 that may be used in spinal cord stimulation (SCS), as well as other stimulation applications.
- the therapy delivery system 10 generally includes an implantable pulse generator 12 (“IPG”) (“IPG”), an implantable therapy delivery element 14 , which carries an array of electrodes 18 (shown exaggerated for purposes of illustration), and an optional implantable extension lead 16 . Although only one therapy delivery element 14 is shown, typically two or more therapy delivery elements 14 are used with the therapy delivery system 10 .
- the therapy delivery element 14 includes lead body 40 having a proximal end 36 and a distal end 44 .
- the lead body 40 typically has a diameter of between about 0.03 inches to 0.07 inches and a length within the range of 30 cm to 90 cm for spinal cord stimulation applications.
- the lead body 40 may include a suitable electrically insulative costing, such as, a polymer (e.g., polyurethane or silicone).
- proximal end 36 of the therapy delivery element 14 is electrically coupled to distal end 38 of the extension lead 16 via a connector 20 , typically associated with the extension lead 16 .
- Proximal end 42 of the extension lead 16 is electrically coupled to the implantable pulse generator 12 via connector 22 associated with housing 28 .
- the proximal end 36 of the therapy delivery element 14 can be electrically coupled directly to the connector 22 .
- the implantable pulse generator 12 includes electronic subassembly 24 (shown schematically), which includes control and pulse generation circuitry (not shown) for delivering electrical stimulation energy to the electrodes 18 of the therapy delivery element 14 in a controlled manner, and a power supply, such as battery 26 .
- the implantable pulse generator 12 provides a programmable stimulation signal (e.g., in the form of electrical pulses or substantially continuous-time signals) that is delivered to target stimulation sites by electrodes 18 .
- a programmable stimulation signal e.g., in the form of electrical pulses or substantially continuous-time signals
- the implantable pulse generator 12 may provide the same or a different signal to the electrodes 18 .
- the implantable pulse generator 12 can take the form of an implantable receiver-stimulator in which the power source for powering the implanted receiver, as well as control circuitry to command the receiver-stimulator, are contained in an external controller inductively coupled to the receiver-stimulator via an electromagnetic link.
- the implantable pulse generator 12 can take the form of an external trial stimulator (ETS), which has similar pulse generation circuitry as an IPG, but differs in that it is a non-implantable device that is used on a trial basis after the therapy delivery element 14 has been implanted and prior to implantation of the IPG, to test the responsiveness of the stimulation that is to be provided.
- ETS external trial stimulator
- the housing 28 is composed of a biocompatible material, such as for example titanium, and forms a hermetically sealed compartment containing the electronic subassembly 24 and battery 26 protected from the body tissue and fluids.
- the connector 22 is disposed in a portion of the housing 28 that is, at least initially, not sealed.
- the connector 22 carries a plurality of contacts that electrically couple with respective terminals at proximal ends of the therapy delivery element 14 or extension lead 16 . Electrical conductors extend from the connector 22 and connect to the electronic subassembly 24 .
- FIG. 2 illustrates the therapy delivery element 14 implanted in the epidural space 30 of a patient in close proximity to the dura, the outer layer that surrounds the spinal cord 32 , to deliver the intended therapeutic effects of spinal cord electrical stimulation.
- the target stimulation sites may be anywhere along the spinal cord 32 , such as for example proximate the sacral nerves.
- the implantable pulse generator 12 is generally implanted in a surgically-made pocket either in the abdomen or above the buttocks, such as illustrated in FIG. 3 .
- the implantable pulse generator 12 may, of course, also be implanted in other locations of the patient's body.
- Use of the extension lead 16 facilitates locating the implantable pulse generator 12 away from the lead exit point 34 .
- the extension lead 16 serves as a lead adapter if the proximal end 36 of the therapy delivery element 14 is not compatible with the connector 22 of the implantable pulse generator 12 , since different manufacturers use different connectors at the ends of their stimulation leads and are not always compatible with the connector 22 .
- the therapy delivery system 10 also may include a clinician programmer 46 and a patient programmer 48 .
- Clinician programmer 46 may be a handheld computing device that permits a clinician to program neurostimulation therapy for patient using input keys and a display.
- the clinician may specify neurostimulation parameters for use in delivery of neurostimulation therapy.
- Clinician programmer 46 supports telemetry (e.g., radio frequency telemetry) with the implantable pulse generator 12 to download neurostimulation parameters and, optionally, upload operational or physiological data stored by implantable pulse generator 12 . In this manner, the clinician may periodically interrogate the implantable pulse generator 12 to evaluate efficacy and, if necessary, modify the stimulation parameters.
- patient programmer 48 may be a handheld computing device. Patient programmer 48 may also include a display and input keys to allow patient to interact with patient programmer 48 and the implantable pulse generator 12 . The patient programmer 48 provides patient with an interface for control of neurostimulation therapy provided by the implantable pulse generator 12 . For example, patient may use patient programmer 48 to start, stop or adjust neurostimulation therapy. In particular, patient programmer 48 may permit patient to adjust stimulation parameters such as duration, amplitude, pulse width and pulse rate, within an adjustment range specified by the clinician via clinician programmer 46 , or select from a library of stored stimulation therapy programs.
- stimulation parameters such as duration, amplitude, pulse width and pulse rate
- the implantable pulse generator 12 , clinician programmer 46 , and patient programmer 48 may communicate via cables or a wireless communication.
- Clinician programmer 46 and patient programmer 48 may, for example, communicate via wireless communication with the implantable pulse generator 12 using RF telemetry techniques known in the art.
- Clinician programmer 46 and patient programmer 48 also may communicate with each other using any of a variety of local wireless communication techniques, such as RF communication according to the 802.11 or Bluetooth specification sets, infrared communication, e.g., according to the IrDA standard, or other standard or proprietary telemetry protocols.
- FIG. 3 also illustrates a general environmental that may benefit from use of a tunneling tool in accordance with an embodiment of the present disclosure.
- the therapy delivery element 14 and/or the extension lead 16 is typically routed through a pathway 52 subcutaneously formed along the torso of the patient to a subcutaneous pocket 54 where the implantable pulse generator 12 is located.
- pathway 52 subcutaneously formed along the torso of the patient to a subcutaneous pocket 54 where the implantable pulse generator 12 is located.
- “lead” and “lead extension” are used interchangeably, unless content clearly dictates otherwise.
- the therapy delivery elements 14 are typically fixed in place near the location selected by the clinician using the present suture anchors 60 .
- the suture anchors 60 can be positioned on the therapy delivery element 14 in a wide variety of locations and orientations to accommodate individual anatomical differences and the preferences of the clinician.
- the suture anchors 60 may then be affixed to tissue using fasteners, such as for example, one or more sutures, staples, screws, or other fixation devices.
- the tissue to which the suture anchors 60 are affixed may include subcutaneous fascia layer, bone, or some other type of tissue. Securing the suture anchors 60 to tissue in this manner prevents or reduces the chance that the therapy delivery element 14 will become dislodged or will migrate in an undesired manner.
- FIG. 4A illustrates the therapy delivery element 14 including one or more electrical contacts 15 at the proximal end 36 , and one or more electrodes 18 at the distal end 44 .
- the contacts 15 and electrodes 18 are electrically coupled via insulated wires running through the therapy delivery element 14 .
- Proximal end 36 of the therapy delivery element 14 is electrically and mechanically coupled to implantable pulse generator 12 by the connector assembly 22 .
- the connector assembly 22 includes a plurality of discrete contacts 23 located in the housing 28 that electrically couple contact rings 15 on the proximal end of the therapy delivery element 14 .
- the discrete contacts 23 are electrically coupled to circuitry 24 in the implantable pulse generator 12 by conductive members 21 .
- Each contact ring 15 is electrically coupled to one or more of the electrodes 18 located at the distal end 44 of the therapy delivery element 14 . Consequently, the implantable pulse generator 12 can independently deliver electrical impulses to each of the electrodes 18 .
- the therapy delivery element 14 can be coupled to the implantable pulse generator 12 through one or more lead extensions 16 , as illustrated in FIG. 4B .
- the connector 20 at the distal end 38 of the lead extension 16 preferably includes a plurality of the contacts 23 configured in a manner similar to the connector assembly 22 .
- FIGS. 5A and 5B illustrate a stylet/lead assembly 70 including the therapy delivery element 14 in accordance with an embodiment of the present disclosure.
- stylet refers to a tool inserted into the lumen of a therapy delivery element, such as a neurostimulation lead, to stiffen the lead body and to facilitate its insertion into a target tissue.
- stylet 72 includes stylet wire 74 attached to handle 76 .
- the stylet wire 74 has a diameter smaller than lumen 78 in the lead body 86 of the therapy delivery element 14 .
- Length 80 is typically the same, or slightly greater than, length 82 of the lumen 78 so the distal end 84 of the stylet wire 74 preferably reaches distal end 85 of the therapy delivery element 14 .
- the distal end 85 of the therapy delivery element is typically sealed, so the length 82 of the lumen 78 is less than the length of the therapy delivery element 14 .
- distal end 84 of the stylet wire 74 is inserted in lumen 78 of the therapy delivery element 14 to create the stylet/lead assembly 70 .
- stylet wires for the SCS application are typically made of stainless steel or tungsten.
- Super-elastic materials provide excellent kink resistance but have poor resistance to buckling forces and torque. Consequently, a stylet wire 74 made from these materials alone is not be suitable for use for SCS therapy delivery elements.
- Stylet wires manufactured from combinations of linear and super-elastic materials have been evaluated, as disclosed in U.S. Pat. Nos. 6,214,016; 6,168,571; 5,238,004; 6,270,496 and 5,957,966, which are hereby incorporated by reference.
- FIGS. 6A and 6B are cut-away views of a conductor assembly 100 for the lead body 86 having an inner coil 102 and outer coil 104 in accordance with an embodiment of the present disclosure.
- the inner coil 102 includes a plurality of discrete electrical conductors 106 each covered with an insulator 108 and helically wound in a first direction 110 around lumen 78 that receives stylet wire 74 .
- the outer coil 104 includes a plurality of discrete electrical conductors 112 each covered with an insulator 114 and helically wound in a second opposite direction 116 .
- the insulators 108 , 114 provide electrical integrity between each electrical conductor 106 , 112 in the conductor assembly 100 .
- the pitch of the inner and outer coils 102 , 104 can be the same or different.
- Insulator 118 surrounds both the inner and outer coils 102 , 104 .
- the insulator 118 is preferably a rubber-elastic, bendable and biologically compatible material, such as for example, an elastomer on a polyurethane or silicon base.
- the conductor assembly 100 preferably includes at least one electrical conductor 106 , 112 for each electrode 18 .
- the inner and outer coils 102 , 104 each include four electrical conductors 106 , 112 , to support an eight-electrode lead.
- the inner coil 102 includes four electrical conductors 106 and the outer coil 104 includes eight electrical conductors 112 , to support a twelve-electrode lead. Any number of electrical conductors 106 , 112 can be used in the present conductor assembly 100 to provide the desired number of circuit paths for the electrodes.
- the inner coil 102 is preferably in direct physical contact with the outer coil 104 , reducing the size of the conductor assembly 100 and increasing the density of available circuit paths. Winding the electrical conductors 106 , 112 in opposite directions 110 , 116 permits movement of the inner coil 102 relative to the outer coil 104 and permits the conductor assembly 100 to be bent with such a small radius of curvature without permanent or lasting deformation.
- the inner and outer coils 102 , 104 also permit the conductor assembly 100 to elastically expandable in longitudinal direction 130 . Configuring the coils 102 , 104 as opposing helical coils also enhances torque transfer by the lead body 86 . The increased torque transfer aids during implantation of the therapy delivery element 14 .
- the electrical conductors 106 , 112 can include a single conductive element, a plurality of conductive wires, or a combination thereof. As illustrated in FIG. 6C , one or more of the electrical conductors 106 , 112 optionally include a plurality of un-insulated conductive wires 120 a - 120 g (collectively “ 120 ”) twisted in a ropelike configuration 122 . Insulator 124 surrounds the conductive wires 120 to form one of the electrical conductor 106 , 112 , also referred to a cable.
- the wires 120 are preferably not rigidly connected together, but rather, only contact one another and can move with respect to one another within certain limits.
- the six outer wires 120 a - 120 f are uniformly distributed around the center wire 120 g .
- the outer wires 120 a - 120 f are preferably composites including a core 126 of a first material and a covering 128 of a second material.
- the core 126 preferably has greater electrical conductivity than the covering 128 and the covering 128 preferably has a greater breaking strength and better biocompatibility than the core 126 .
- the core 126 can be silver or copper and the covering 128 can be a nickel-cobalt-chromium-molybdenum alloy, such as for example, MP35N.
- the center wire 120 g is preferably constructed from a material with a greater breaking strength than the six outer wires 120 a - 120 f .
- the center wire 120 g can optionally be constructed from a non-conductive material, such as for example a monofilament.
- the center wire 120 g is constructed from the same material as the covering layer 128 .
- the center wire 120 g can be one of a variety of alloys, such as the CoNiCrMoWFe alloy (standard ASTM F 563-78) supplied under the commercial name Syntacoben by Institut Straumann AG, Switzerland; the CoCrFeNi alloy supplied under the commercial name Elgiloy by Elgin National Watch Co., U.S.A.; stainless steel, such as the Fe, Cr, Ni, Mo containing steel (standards ISO 5832/1; ASTM F 138-76) commercially available under the designation 316 L; or a variety of other materials disclosed in U.S. Pat. No. 4,640,983 (Comte), which is hereby incorporated by reference.
- alloys such as the CoNiCrMoWFe alloy (standard ASTM F 563-78) supplied under the commercial name Syntacoben by Institut Straumann AG, Switzerland; the CoCrFeNi alloy supplied under the commercial name Elgiloy by Elgin National Watch Co., U
- Bending stress, or flexure stress varies with position throughout the cross section of the wires 120 . Stress is zero at the center of the wires 120 , but increases with distance from the center. Since the maximum stress occurs at the surface of the wires 120 , using a composite material with the strongest material on the covering 128 provides significant advantage by allowing greater stress without permanent deformation. Since minimal stress occurs in the core 126 of the wire 120 , it is less important that the core material be strong.
- FIG. 7A is a cross sectional view conductor assembly 150 in which the electrical conductors 152 for the inner coil 154 and the electrical conductors 156 for the outer coil 158 each include a plurality of un-insulated wires 160 surrounded by an insulating layer 162 in accordance with an embodiment of the present disclosure.
- the electrical conductors 152 in the inner coil 154 contact the electrical conductors 156 of the outer coil 158 at a plurality of interfaces 164 .
- FIG. 7B is a cross sectional view conductor assembly 170 in which the electrical conductors 172 for the outer coil 174 each include a plurality of un-insulated wires 176 surrounded by an insulating layer 178 , and the inner coil 180 includes a plurality of insulated electrical conductors 182 each with a single conductive element in accordance with an embodiment of the present disclosure.
- the electrical conductors 172 in the outer coil 174 contact the electrical conductors 182 of the inner coil 180 at a plurality of interfaces 184 .
- FIG. 7C is a cross sectional view conductor assembly 190 in which the electrical conductors 172 of the outer coil 174 are a plurality of insulated electrical conductors 182 each with a single conductive element and the electrical conductors 182 of the inner coil 180 are a plurality of un-insulated wires 176 surrounded by an insulating layer 178 in accordance with an embodiment of the present disclosure.
- FIG. 7D is a cross sectional view conductor assembly 192 in which the electrical conductors 172 , 182 in both the inner and outer coils 180 , 174 are a plurality of insulated electrical conductors 182 each with a single conductive element in accordance with an embodiment of the present disclosure. In both embodiments, the electrical conductors 172 in the outer coil 174 contact the electrical conductors 182 of the inner coil 180 at a plurality of interfaces 184 .
- FIG. 8 is a flow chart of a method of making a therapy delivery element adapted for at least partial insertion in a living body in accordance with an embodiment of the present disclosure.
- a plurality of the first electrical conductors each covered with an insulator are helically wound in a first direction to form an inner coil with a lumen ( 200 ).
- a plurality of second electrical conductors are helically wound in a second opposite direction forming an outer coil in direct physical contact with the inner coil.
- Each of the second electrical conductors includes a plurality of un-insulated wires twisted in a ropelike configuration around a central axis to form a cable covered with an insulator ( 202 ).
- An insulator covering is applied to the inner and outer coils to form a lead body ( 204 ). At least one electrically conductive connector is attached to a proximal end of the lead body and at least one electrode is attached to a distal end of the lead body ( 206 ). Each matched set of connectors and electrodes are electrically coupled with one of the first or second electrical conductors ( 208 ).
- FIG. 9 is a flow chart of a method of implanting a neurostimulation system in accordance with an embodiment of the present disclosure.
- a distal end of a stylet wire is inserted into the lumen through an opening at the proximal end of the therapy delivery element of FIG. 8 ( 220 ).
- the surgeon grasps a stylet handle attached to the stylet wire to steer the electrodes at the distal end of a therapy delivery element to a target location within the living body ( 222 ).
- the stylet is removed from the therapy delivery element ( 224 ).
- An implantable pulse generator is implanted within the living body ( 226 ). Electrical contacts at the proximal end of the therapy delivery element are electrically coupled with the implantable pulse generator ( 228 ).
Abstract
Description
Claims (20)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/220,913 US8560084B2 (en) | 2011-08-30 | 2011-08-30 | Lead body with inner and outer co-axial coils |
EP12171266.5A EP2564892B1 (en) | 2011-08-30 | 2012-06-08 | Lead body with inner and outer co-axial coils |
US14/024,668 US9002476B2 (en) | 2011-08-30 | 2013-09-12 | Lead body with inner and outer co-axial coils |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/220,913 US8560084B2 (en) | 2011-08-30 | 2011-08-30 | Lead body with inner and outer co-axial coils |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/024,668 Continuation US9002476B2 (en) | 2011-08-30 | 2013-09-12 | Lead body with inner and outer co-axial coils |
Publications (2)
Publication Number | Publication Date |
---|---|
US20130053864A1 US20130053864A1 (en) | 2013-02-28 |
US8560084B2 true US8560084B2 (en) | 2013-10-15 |
Family
ID=46245894
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/220,913 Active 2032-01-09 US8560084B2 (en) | 2011-08-30 | 2011-08-30 | Lead body with inner and outer co-axial coils |
US14/024,668 Active US9002476B2 (en) | 2011-08-30 | 2013-09-12 | Lead body with inner and outer co-axial coils |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/024,668 Active US9002476B2 (en) | 2011-08-30 | 2013-09-12 | Lead body with inner and outer co-axial coils |
Country Status (2)
Country | Link |
---|---|
US (2) | US8560084B2 (en) |
EP (1) | EP2564892B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140214145A1 (en) * | 2013-01-25 | 2014-07-31 | Med-El Elektromedizinische Geraete Gmbh | Impact Protection for Implantable Electric Lead |
US11511122B2 (en) | 2018-02-22 | 2022-11-29 | Axonics, Inc. | Neurostimulation leads for trial nerve stimulation and methods of use |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2719422B1 (en) * | 2012-10-12 | 2015-02-18 | Sorin CRM SAS | Implantable multipolar detection/stimulation microprobe |
US9770598B2 (en) * | 2014-08-29 | 2017-09-26 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using improved connector contacts for electrical stimulation systems |
US9956394B2 (en) | 2015-09-10 | 2018-05-01 | Boston Scientific Neuromodulation Corporation | Connectors for electrical stimulation systems and methods of making and using |
US10342983B2 (en) | 2016-01-14 | 2019-07-09 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using connector contact arrays for electrical stimulation systems |
US10201713B2 (en) | 2016-06-20 | 2019-02-12 | Boston Scientific Neuromodulation Corporation | Threaded connector assembly and methods of making and using the same |
US10307602B2 (en) | 2016-07-08 | 2019-06-04 | Boston Scientific Neuromodulation Corporation | Threaded connector assembly and methods of making and using the same |
US10543374B2 (en) | 2016-09-30 | 2020-01-28 | Boston Scientific Neuromodulation Corporation | Connector assemblies with bending limiters for electrical stimulation systems and methods of making and using same |
US10905871B2 (en) | 2017-01-27 | 2021-02-02 | Boston Scientific Neuromodulation Corporation | Lead assemblies with arrangements to confirm alignment between terminals and contacts |
US10814136B2 (en) | 2017-02-28 | 2020-10-27 | Boston Scientific Neuromodulation Corporation | Toolless connector for latching stimulation leads and methods of making and using |
US10603499B2 (en) | 2017-04-07 | 2020-03-31 | Boston Scientific Neuromodulation Corporation | Tapered implantable lead and connector interface and methods of making and using |
WO2019023067A1 (en) | 2017-07-25 | 2019-01-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using an enhanced connector of an electrical stimulation system |
AU2018331521B2 (en) | 2017-09-15 | 2021-07-22 | Boston Scientific Neuromodulation Corporation | Biased lead connector for operating room cable assembly and methods of making and using |
AU2018331512B2 (en) | 2017-09-15 | 2021-06-24 | Boston Scientific Neuromodulation Corporation | Actuatable lead connector for an operating room cable assembly and methods of making and using |
US11139603B2 (en) | 2017-10-03 | 2021-10-05 | Boston Scientific Neuromodulation Corporation | Connectors with spring contacts for electrical stimulation systems and methods of making and using same |
US11103712B2 (en) | 2018-01-16 | 2021-08-31 | Boston Scientific Neuromodulation Corporation | Connector assemblies with novel spacers for electrical stimulation systems and methods of making and using same |
EP3790623B1 (en) | 2018-05-11 | 2023-07-05 | Boston Scientific Neuromodulation Corporation | Connector assembly for an electrical stimulation system |
USD934438S1 (en) | 2018-06-29 | 2021-10-26 | Spr Therapeutics, Inc. | Lead placement tool |
CN112399869A (en) * | 2018-07-23 | 2021-02-23 | 领先仿生公司 | Reinforced electrode lead and manufacturing method thereof |
US11357992B2 (en) | 2019-05-03 | 2022-06-14 | Boston Scientific Neuromodulation Corporation | Connector assembly for an electrical stimulation system and methods of making and using |
US20210106838A1 (en) * | 2019-10-11 | 2021-04-15 | Medtronic, Inc. | Medical device with braided tubular body |
DE202021104261U1 (en) * | 2021-08-10 | 2021-08-13 | Biotronik Se & Co. Kg | Braided helical leads for implantable electrodes |
CN216258739U (en) * | 2021-10-19 | 2022-04-12 | 苏州景昱医疗器械有限公司 | Implantable medical device and medical lead thereof |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4640983A (en) | 1984-04-09 | 1987-02-03 | Institut Straumann Ag | Conductor device, particularly for at least partial insertion in a human or animal body, comprising a spiral formed from at least one conductor |
US4945342A (en) * | 1987-10-16 | 1990-07-31 | Instit Straumann | Electrical cable for performing stimulations and/or measurements inside a human or animal body and method of manufacturing the cable |
US4964414A (en) | 1987-08-27 | 1990-10-23 | Yasunobu Handa | Electrode for use in implanting in a living body |
US5330521A (en) | 1992-06-29 | 1994-07-19 | Cohen Donald M | Low resistance implantable electrical leads |
US5483022A (en) | 1994-04-12 | 1996-01-09 | Ventritex, Inc. | Implantable conductor coil formed from cabled composite wire |
US6295476B1 (en) | 1999-11-01 | 2001-09-25 | Medtronic, Inc. | Medical lead conductor fracture visualization method and apparatus |
US6456888B1 (en) | 2000-08-18 | 2002-09-24 | Cardiac Pacemakers, Inc. | Geometry for coupling and electrode to a conductor |
US20030050680A1 (en) | 2001-09-07 | 2003-03-13 | Gibson Scott R. | Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same |
US20040078070A1 (en) | 2001-06-28 | 2004-04-22 | Medtronic, Inc. | Law impedance implantable extension for a neurological electrical stimulator |
US6920361B2 (en) | 2003-02-14 | 2005-07-19 | Medtronic, Inc. | Reverse wound electrodes |
US6978185B2 (en) | 2001-11-09 | 2005-12-20 | Oscor Inc. | Multifilar conductor for cardiac leads |
US20060089697A1 (en) | 2004-10-21 | 2006-04-27 | Medtronic, Inc. | Implantable medical lead |
US20060200216A1 (en) | 2005-03-07 | 2006-09-07 | Calzada Javier E | Fabrication of electrical medical leads employing multi-filar wire conductors |
US20060229693A1 (en) | 2005-03-31 | 2006-10-12 | Bauer Ryan T | Medical electrical lead with co-radial multi-conductor coil |
US20070179577A1 (en) | 2006-01-31 | 2007-08-02 | Marshall Mark T | Medical electrical lead having improved inductance |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5238004A (en) | 1990-04-10 | 1993-08-24 | Boston Scientific Corporation | High elongation linear elastic guidewire |
US5246014A (en) * | 1991-11-08 | 1993-09-21 | Medtronic, Inc. | Implantable lead system |
US5760341A (en) * | 1996-09-10 | 1998-06-02 | Medtronic, Inc. | Conductor cable for biomedical lead |
US6096036A (en) | 1998-05-05 | 2000-08-01 | Cardiac Pacemakers, Inc. | Steerable catheter with preformed distal shape and method for use |
US6042553A (en) | 1997-04-15 | 2000-03-28 | Symbiosis Corporation | Linear elastic member |
US5957966A (en) | 1998-02-18 | 1999-09-28 | Intermedics Inc. | Implantable cardiac lead with multiple shape memory polymer structures |
US6214016B1 (en) | 1999-04-29 | 2001-04-10 | Medtronic, Inc. | Medical instrument positioning device internal to a catheter or lead and method of use |
US8160719B2 (en) | 2006-12-19 | 2012-04-17 | Greatbatch Ltd. | Braided electrical lead |
US8364281B2 (en) * | 2008-11-07 | 2013-01-29 | W. L. Gore & Associates, Inc. | Implantable lead |
-
2011
- 2011-08-30 US US13/220,913 patent/US8560084B2/en active Active
-
2012
- 2012-06-08 EP EP12171266.5A patent/EP2564892B1/en active Active
-
2013
- 2013-09-12 US US14/024,668 patent/US9002476B2/en active Active
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4640983A (en) | 1984-04-09 | 1987-02-03 | Institut Straumann Ag | Conductor device, particularly for at least partial insertion in a human or animal body, comprising a spiral formed from at least one conductor |
US4964414A (en) | 1987-08-27 | 1990-10-23 | Yasunobu Handa | Electrode for use in implanting in a living body |
US4945342A (en) * | 1987-10-16 | 1990-07-31 | Instit Straumann | Electrical cable for performing stimulations and/or measurements inside a human or animal body and method of manufacturing the cable |
US5330521A (en) | 1992-06-29 | 1994-07-19 | Cohen Donald M | Low resistance implantable electrical leads |
US5483022A (en) | 1994-04-12 | 1996-01-09 | Ventritex, Inc. | Implantable conductor coil formed from cabled composite wire |
US6295476B1 (en) | 1999-11-01 | 2001-09-25 | Medtronic, Inc. | Medical lead conductor fracture visualization method and apparatus |
US6456888B1 (en) | 2000-08-18 | 2002-09-24 | Cardiac Pacemakers, Inc. | Geometry for coupling and electrode to a conductor |
US20040078070A1 (en) | 2001-06-28 | 2004-04-22 | Medtronic, Inc. | Law impedance implantable extension for a neurological electrical stimulator |
US6671554B2 (en) | 2001-09-07 | 2003-12-30 | Medtronic Minimed, Inc. | Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same |
US20030050680A1 (en) | 2001-09-07 | 2003-03-13 | Gibson Scott R. | Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same |
US6978185B2 (en) | 2001-11-09 | 2005-12-20 | Oscor Inc. | Multifilar conductor for cardiac leads |
US6920361B2 (en) | 2003-02-14 | 2005-07-19 | Medtronic, Inc. | Reverse wound electrodes |
US20060089697A1 (en) | 2004-10-21 | 2006-04-27 | Medtronic, Inc. | Implantable medical lead |
US20060200216A1 (en) | 2005-03-07 | 2006-09-07 | Calzada Javier E | Fabrication of electrical medical leads employing multi-filar wire conductors |
US20060229693A1 (en) | 2005-03-31 | 2006-10-12 | Bauer Ryan T | Medical electrical lead with co-radial multi-conductor coil |
US20070179577A1 (en) | 2006-01-31 | 2007-08-02 | Marshall Mark T | Medical electrical lead having improved inductance |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140214145A1 (en) * | 2013-01-25 | 2014-07-31 | Med-El Elektromedizinische Geraete Gmbh | Impact Protection for Implantable Electric Lead |
US9174039B2 (en) * | 2013-01-25 | 2015-11-03 | Med-El Elektromedizinische Geraete Gmbh | Impact protection for implantable electric lead |
US9433777B2 (en) | 2013-01-25 | 2016-09-06 | Med-El Elektromedizinische Geraete Gmbh | Impact protection for implantable electric lead |
US9839778B2 (en) | 2013-01-25 | 2017-12-12 | MED-EL Elektromedizinische Geratete GmbH | Impact protection for implantable electric lead |
US11511122B2 (en) | 2018-02-22 | 2022-11-29 | Axonics, Inc. | Neurostimulation leads for trial nerve stimulation and methods of use |
Also Published As
Publication number | Publication date |
---|---|
US20140018895A1 (en) | 2014-01-16 |
EP2564892B1 (en) | 2014-10-15 |
US9002476B2 (en) | 2015-04-07 |
EP2564892A1 (en) | 2013-03-06 |
US20130053864A1 (en) | 2013-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9002476B2 (en) | Lead body with inner and outer co-axial coils | |
US10661077B2 (en) | Manufacturing method of a dynamic coil for implantable stimulation leads | |
US8738153B2 (en) | Implantable lead with braided conductors | |
US11160974B2 (en) | Neurostimulation lead with stiffened proximal array | |
US11020586B2 (en) | Distally curved electrical stimulation lead and methods of making and using | |
US9833611B2 (en) | Systems and methods for making and using improved contact arrays for electrical stimulation systems | |
US9026227B2 (en) | Anchor sleeve for implantable lead | |
EP2593178B1 (en) | Tunneling tool for implantable leads | |
US6671544B2 (en) | Low impedance implantable extension for a neurological electrical stimulator | |
US9067056B2 (en) | Lead spacer tool | |
US9320888B2 (en) | Adjustable wire length stylet handle | |
US10124161B2 (en) | Neurostimulation lead with conductive elements and methods for making the same | |
US10179234B2 (en) | Distally reinforced lead and methods of making and using | |
US20220226641A1 (en) | Electrical stimulation cuff devices and systems with directional electrode configurations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: GREATBATCH LTD., NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GEROY, JESSE;SWOYER, JOHN;REEL/FRAME:026827/0302 Effective date: 20110819 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: MANUFACTURERS AND TRADERS TRUST COMPANY, NEW YORK Free format text: SECURITY INTEREST;ASSIGNORS:GREATBATCH, INC.;GREATBATCH LTD.;ELECTROCHEM SOLUTIONS, INC.;AND OTHERS;REEL/FRAME:036980/0482 Effective date: 20151027 |
|
AS | Assignment |
Owner name: QIG GROUP, LLC, NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GREATBATCH LTD.;REEL/FRAME:037810/0051 Effective date: 20160212 |
|
AS | Assignment |
Owner name: NUVECTRA CORPORATION, TEXAS Free format text: CHANGE OF NAME;ASSIGNOR:QIG GROUP, LLC;REEL/FRAME:038455/0153 Effective date: 20160314 |
|
AS | Assignment |
Owner name: NEURONEXUS TECHNOLOGIES, INC., MICHIGAN Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY;REEL/FRAME:039132/0773 Effective date: 20160418 Owner name: ELECTROCHEM SOLUTIONS, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY;REEL/FRAME:039132/0773 Effective date: 20160418 Owner name: GREATBATCH INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY;REEL/FRAME:039132/0773 Effective date: 20160418 Owner name: MICRO POWER ELECTRONICS, INC., OREGON Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY;REEL/FRAME:039132/0773 Effective date: 20160418 Owner name: QIG GROUP LLC, TEXAS Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY;REEL/FRAME:039132/0773 Effective date: 20160418 Owner name: GREATBATCH LTD., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY;REEL/FRAME:039132/0773 Effective date: 20160418 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: CIRTEC MEDICAL CORP., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NUVECTRA CORPORATION;REEL/FRAME:052185/0680 Effective date: 20200317 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |
|
AS | Assignment |
Owner name: MICRO POWER ELECTRONICS, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069 Effective date: 20210903 Owner name: PRECIMED INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069 Effective date: 20210903 Owner name: GREATBATCH-GLOBE TOOL, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069 Effective date: 20210903 Owner name: NEURONEXUS TECHNOLOGIES, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069 Effective date: 20210903 Owner name: ELECTROCHEM SOLUTIONS, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069 Effective date: 20210903 Owner name: GREATBATCH LTD., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069 Effective date: 20210903 Owner name: GREATBATCH, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069 Effective date: 20210903 |
|
AS | Assignment |
Owner name: MICRO POWER ELECTRONICS, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858 Effective date: 20210903 Owner name: PRECIMED INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858 Effective date: 20210903 Owner name: GREATBATCH-GLOBE TOOL, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858 Effective date: 20210903 Owner name: NEURONEXUS TECHNOLOGIES, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858 Effective date: 20210903 Owner name: ELECTROCHEM SOLUTIONS, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858 Effective date: 20210903 Owner name: GREATBATCH LTD., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858 Effective date: 20210903 Owner name: GREATBATCH, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858 Effective date: 20210903 |
|
AS | Assignment |
Owner name: BMO HARRIS BANK N.A., AS COLLATERAL AGENT, ILLINOIS Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:CIRTEC MEDICAL CORP.;REEL/FRAME:062559/0098 Effective date: 20230130 |